Platelet-rich plasma therapy provided significant, durable relief of chronic noncancer pain, outperforming both corticosteroid and hyaluronic acid injections.

Regional West Physicians Clinic-Rehabilitation Medicine now offers noninvasive procedures using Regenexx injectates that use ...

Dr. MedLaw explains the importance of discussing risks, benefits, and alternatives in a manner the patient fully understands ...

Platelet-rich plasma (PRP) is a commonly used treatment for tendinopathies such as tennis elbow despite the questionable evidence of its efficacy. A recent Cochrane review suggests that it likely does ...

From November 2009 until December 2010, 91 patients with 100 articular joints were treated with autologous ADSCs in the form of stromal vascular fraction (SVF) along with autologous PRP.

Platelet-rich plasma injections for the treatment of chronic Achilles tendinopathy has become increasingly popular among sports medicine physicians as an alternative to surgery.

The newly formed joint venture combines Centex’s agility, innovation, and socio-economic status with Sterling’s deep federal expertise, contract performance history, and industry buying power.

The knee hyaluronic acid injections market is expected to grow from USD 2.28 billion in 2025 to USD 3.97 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% during the forecast ...

We study the problem of joint source and sensor localization from time-of-arrival (TOA) measurements. For the case of nine sources and four sensors (or, by symmetry, vice versa), we derive a ...

Mitsui O.S.K. Lines, Ltd. (MOL), PETRONAS CCS Ventures Sdn. Bhd. (PCCSV), and MISC BERHAD (MISC) have announced the establishment of a joint venture company, Jules Nautica Sdn. Bhd., to lead the ...

MELBOURNE/NEW YORK - Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage pharmaceutical company with a market capitalization of $19.5 million, announced Tuesday it has entered a 50:50 joint ...